Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Neuropharmacology|September 27, 2005
Developmentally regulated expression of VGLUT3 during early post-natal lifeChristelle Gras, Jacqueline Vinatier, Bénédicte Amilhon, et al.
BMC Cell Biology|February 18, 2005
Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomasRoxane Oliveira, Christo Christov, Jean Sébastien Guillamo, et al.
Chemmedchem|December 7, 2010
Integrated synthetic, pharmacological, and computational investigation of cis-2-(3,5-dichlorophenylcarbamoyl)cyclohexanecarboxylic acid enantiomers as positive allosteric modulators of metabotropic glutamate receptor subtype 4Christo Christov, Patricia González-Bulnes, Fanny Malhaire, et al.
Neuromuscular Disorders : NMD|April 18, 2006
AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic backgroundFrançois-Jérôme Authier, Stéphane Sauvat, Christo Christov, et al.
Cell Death and Differentiation|December 15, 2018
Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cellsMarion Orsini, Sébastien Chateauvieux, Jiyun Rhim, et al.
Respiratory Care|November 6, 2014
Description and microbiology of endotracheal tube biofilm in mechanically ventilated subjectsPierre-Eric Danin, Emmanuelle Girou, Patrick Legrand, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|April 6, 2022
Prenatal Diagnosis of COL4A1 Mutations in Eight Cases: Further Delineation of the Neurohistopathological PhenotypeFrancesca Gubana, Christo Christov, Thibault Coste, et al.
Molecular Cancer Therapeutics|February 27, 2004
Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivoNathalie Laurent, Sophie de Boüard, Jean-Sébastien Guillamo, et al.
Human Gene Therapy|June 28, 2003
Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatinSophie De Boüard, Jean-Sébastien Guillamo, Christo Christov, et al.
Marine Drugs|June 2, 2021
Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477Sungmi Song, Sua Kim, Eslam R El-Sawy, et al.
Pageof 6